Who owns the VERTEX CELL AND GENETIC THERAPIES trademark?

The VERTEX CELL AND GENETIC THERAPIES trademark is owned by Vertex Pharmaceuticals Incorporated.

What class is the VERTEX CELL AND GENETIC THERAPIES trademark registered in?

The VERTEX CELL AND GENETIC THERAPIES trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for VERTEX CELL AND GENETIC THERAPIES?

The USPTO serial number for VERTEX CELL AND GENETIC THERAPIES is 98195949.

What is the registration number for VERTEX CELL AND GENETIC THERAPIES?

VERTEX CELL AND GENETIC THERAPIES is registered under USPTO registration number 7883674.

VER

USPTO Trademark Record

REGISTERED

VERTEX CELL AND GENETIC THERAPIES

SN 98195949·Reg 7883674·Filed Sep 25, 2023

Owner Vertex Pharmaceuticals Incorporated

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

VERTEX CELL AND GENETIC THERAPIES (Serial No. 98195949), Registration No. 7883674, is a registered US trademark filed on Sep 25, 2023 by Vertex Pharmaceuticals Incorporated. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: August 05, 2031

Mark Intelligence

VERTEX CELL AND GENETIC THERAPIES (Reg. #7883674) is a registered US trademark that has been protecting its owner, Vertex Pharmaceuticals Incorporated, since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 25, 2023

SERIAL

98195949

REG#

7883674

REGISTERED

Aug 05, 2025

Owner

Applicant

Vertex Pharmaceuticals Incorporated

Entity

Corporation

State

Address

50 Northern Avenue, Boston, MA, 02210

Country

Attorney

NameLisa Tittemore

Law firm

Lisa Tittemore Merchant & Gould P.C.

Address

P.O. Box 2910, Minneapolis, MN 55402-0910, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 25, 2023

Serial Number98195949

Registration No.7883674

Registration DateAug 05, 2025

Status DateAug 05, 2025

Published for OppositionJul 30, 2024

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jun 06, 2024

First use in commerce: Jun 06, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

25 events

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 02, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 02, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 02, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Aug 05, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 05, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 16, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 12, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 22, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Jun 22, 2025

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Mar 21, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Mar 21, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 24, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 30, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Jul 30, 2024

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 10, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 21, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 20, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 20, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 20, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Apr 05, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 05, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 05, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 29, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 10, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 28, 2023

NEW APPLICATION ENTERED

VERTEX CELL AND GENETIC THERAPIES

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Vertex Pharmaceuticals Incorporated

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Lisa Tittemore

Resources

Company